THYMAGEN

Part of the Khavinson bioregulator family, this synthetic dipeptide consists of just two amino acids: glutamic acid and tryptophan. Developed by Russian researchers studying aging and immune decline, it targets the thymus gland—the organ responsible for training immune cells that shrinks dramatically as we age. Most research attention has focused on its potential to counteract immunosenescence, the gradual weakening of immune function that occurs with advancing age.

The peptide appears to interact directly with thymic epithelial cells, the specialized cells that create the environment where T-cells learn to recognize threats and develop into mature immune defenders. By potentially enhancing the activity of these thymic cells, it may help maintain the thymus's ability to produce competent T-cells even as the organ naturally deteriorates. Think of it as trying to keep an aging training academy for immune cells functioning at a more youthful level.